K. Weigang-Köhler

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Claus Rödel, Torsten Liersch, Heinz Becker et al. · The Lancet Oncology · 2012 · 700 citations

Medicine, Oncology, Surgery +17

Phase II trial with S-1 in chemotherapy-naıve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)

P. Chollet, Patrick Schöffski, K. Weigang-Köhler et al. · European Journal of Cancer · 2003 · 106 citations

Medicine, Oncology, Chemotherapy +6

A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

Hanno Riess, A. Helm, Marco Niedergethmann et al. · Journal of Clinical Oncology · 2005 · 102 citations

Medicine, Oncology, Pharmacotherapy +14

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

Jan Van den Brande, Patrick Schöffski, Jan H.M. Schellens et al. · British Journal of Cancer · 2003 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

Ch. Dittrich, G. Greim, Markus Borner et al. · European Journal of Cancer · 2002 · 71 citations

Medicine, Pharmacokinetics, Pharmacology +8